Robert Lorne Hopfner - 18 Jun 2024 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
Director
Signature
/s/ Sanjay Subramanian, as attorney-in-fact for Robert Hopfner
Issuer symbol
INZY
Transactions as of
18 Jun 2024
Net transactions value
$0
Form type
4
Filing time
20 Jun 2024, 16:15:36 UTC
Previous filing
17 May 2024
Next filing
06 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INZY Stock Option (right to buy) Award $0 +28,000 $0.000000 28,000 18 Jun 2024 Common Stock 28,000 $4.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on June 18, 2024. The shares underlying the option are scheduled to vest as to 100% of the shares on June 18, 2025, or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date.